Previous Issue - Issue 08
This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
Issue 08 | 2026
- Foreword
- Biopharma
- Strategy
- Research & Development
- Clinical Trials
- Manufacturing
- Information Technology
- Expert Talk
- Advertorials Go to Digital Magazine
Issue 08
PREVIOUS ISSUE
Foreword
Beyond Breakthroughs
Perspectives on Pharma Innovation
The pharmaceutical industry is entering a defining era shaped not only by scientific discovery but also by its ability to
Biopharma
A Taste of What’s to Come
How Functional Excipients Are
Drug formulation has never been more demanding Pharmaceutical developers are increasingly working with challenging
Fine-Tuning ADCs to Improve Outcomes for Patients with Cancer
Balancing potency, precision, and access in next-generation antibody-drug conjugates
Antibodydrug conjugates ADCs have emerged as one of the most promising therapeutic modalities in oncology
Cleaning & Disinfection in Biopharma Manufacturing
Managing Risk Where Biology Allows No Error
Biopharmaceutical manufacturing has always carried an inherent risk of contamination but the nature of that risk
Strategy
The Strategic Rise of Corporate Development in Pharma
For most of the modern pharmaceutical era value creation was synonymous with internal RD
Research & Development
When to Consider Micronisation Early
How Particle Engineering Prevents Costly Bioavailability Failures in Phase I and Beyond
Micronization by spiral jet mill process is the first and the most effective process usually implemented or tested
How GMP-Ready 3D Printers Are Redefining Small-Batch Capsule Filling in Drug Development
From preclinical studies to firstinhuman trials GMPcompliant D printing platforms deliver automated capsule filling
Critical Raw Materials in Oligonucleotide Therapeutics
The Role of Phosphoramidite Monomers and Delivery Molecules
Oligonucleotide therapeutics spanning antisense oligonucleotides ASOs small interfering RNAs siRNAs
Isotopic Labelling in Drug Development
Isotopic labelling continues to be one of the most effective ways of understanding how drug candidates behave once they enter
Clinical Trials
Clinical Trials Are Tightly Controlled - Except for One Critical Variable
Clinical trials have become more complex more distributed and more inclusive in ambition Yet one of the most influential
Relatively Speaking
AI's Recruitment Impact Is Time
The clinical research industry is understandably excited about what artificial intelligence AI will bring to science
Manufacturing
Tailored Artificial Intelligence (AI)
A Systematic, Secure LLM Framework for Advanced Pharmaceutical Manufacturing
The deployment of generalpurpose large language models LLMs in the pharmaceutical industry is constrained
Information Technology
Cloud-Native Drug Discovery
Before the Platform, the Data
The market for cloudnative drug discovery platforms reached USD billion in with of pharma companies
From the “AI Pilot Graveyard” to Enterprise-Grade Impact
Why ERP Modernisation Is Pharma’s Most Underrated AI Strategy
Artificial intelligence is everywhere in the pharmaceutical industry From demand forecasting and quality analytics to GenAI
Expert Talk
Controlling Polysorbate Degradation
From Mechanism to Mitigation
Polysorbates PS are complex heterogeneous mixtures making it difficult to detect lowlevel degradation products
Accelerating Cross-Sector Integration in Pharma and Nutraceuticals
I think where Making Pharmaceuticals sits today is really as a practical accessible platform for the industry
Early-Phase Oncology Trials
Shaping the Future of Cancer Research
For me the story here is the improvement in drugs over the past years and their likelihood of efficacy Since my first introduction
Applied Artificial Intelligence for Drug Discovery
Applied Artificial Intelligence for Drug Discovery was inspired by the rapid integration of AI across the entire pharmaceutical
Advertorials
Arbovirus E Dimer Vaccines
Engineering Safer Immunogens to Circumvent Antibody-Dependent Enhancement
Arboviruses particularly Dengue virus DENV and Zika virus ZIKV represent a massive and escalating global health threat
